mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.05 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.06 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.1 |
0.06 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.06 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.07 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.082 |
0.08 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.08 |